Manning & Napier Group's TMO Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 290.9K shares of Thermo Fisher Scientific Inc. (TMO) worth $141.09 M, representing 1.80% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in TMO, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2020, adding 142.6K shares. Largest reduction occurred in Q3 2016, reducing 217.8K shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Thermo Fisher Scientific (TMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Thermo Fisher Scientific (TMO) Trades by Manning & Napier Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2015 | +504,380 | New Buy | 504,380 | $122.28 |
| Q4 2015 | +81,130 | Add 16.09% | 585,510 | $141.85 |
| Q1 2016 | +102,380 | Add 17.49% | 687,890 | $141.59 |
| Q2 2016 | -56,550 | Reduce 8.22% | 631,340 | $147.76 |
| Q3 2016 | -217,799 | Reduce 34.50% | 413,541 | $159.06 |
| Q4 2016 | +1,670 | Add 0.40% | 415,211 | $141.09 |
| Q1 2017 | -87,708 | Reduce 21.12% | 327,503 | $153.60 |
| Q2 2017 | -55,793 | Reduce 17.04% | 271,710 | $174.47 |
| Q3 2017 | -100,615 | Reduce 37.03% | 171,095 | $189.19 |
| Q4 2017 | +165,471 | Add 0.00% | 165,470 | $189.88 |
| Q1 2018 | -33,540 | Reduce 20.27% | 131,930 | $206.44 |
| Q2 2018 | -4,720 | Reduce 3.58% | 127,210 | $207.12 |
| Q3 2018 | -80 | Reduce 0.06% | 127,130 | $244.07 |
| Q4 2018 | -13,680 | Reduce 10.76% | 113,450 | $223.78 |
| Q1 2019 | -31,700 | Reduce 27.94% | 81,750 | $273.70 |
| Q2 2019 | -1,275 | Reduce 1.56% | 80,475 | $293.66 |
| Q3 2019 | +410 | Add 0.51% | 80,885 | $291.24 |
| Q4 2019 | -4,760 | Reduce 5.88% | 76,125 | $324.86 |
| Q1 2020 | +142,550 | Add 187.26% | 218,675 | $283.59 |
| Q2 2020 | -6,610 | Reduce 3.02% | 212,065 | $362.33 |
| Q3 2020 | -13,018 | Reduce 6.14% | 199,047 | $441.51 |
| Q4 2020 | -18,421 | Reduce 9.25% | 180,626 | $465.77 |
| Q1 2021 | +3,085 | Add 1.71% | 183,711 | $456.37 |
| Q2 2021 | +664 | Add 0.36% | 184,375 | $504.46 |
| Q3 2021 | -5,842 | Reduce 3.17% | 178,533 | $571.32 |
| Q4 2021 | -7,628 | Reduce 4.27% | 170,905 | $667.23 |
| Q1 2022 | -25,613 | Reduce 14.99% | 145,292 | $590.64 |
| Q2 2022 | -3,742 | Reduce 2.58% | 141,550 | $543.27 |
| Q3 2022 | -2,002 | Reduce 1.41% | 139,548 | $507.18 |
| Q4 2022 | -1,612 | Reduce 1.16% | 137,936 | $550.69 |
| Q1 2023 | +1,219 | Add 0.88% | 139,155 | $576.37 |
| Q2 2023 | +1,184 | Add 0.85% | 140,339 | $521.75 |
| Q3 2023 | +2,655 | Add 1.89% | 142,994 | $506.17 |
| Q4 2023 | +2,453 | Add 1.72% | 145,447 | $530.79 |
| Q1 2024 | -1,642 | Reduce 1.13% | 143,805 | $581.20 |
| Q2 2024 | +141,530 | Add 0.00% | 141,529 | $553.00 |
| Q3 2024 | +52,498 | Add 37.09% | 194,027 | $618.57 |
| Q4 2024 | +73,575 | Add 37.92% | 267,602 | $520.23 |
| Q1 2025 | +95,509 | Add 35.69% | 363,111 | $497.60 |
| Q2 2025 | -50,758 | Reduce 13.98% | 312,353 | $405.48 |
| Q3 2025 | -21,457 | Reduce 6.87% | 290,896 | $485.02 |
Manning & Napier Group's Thermo Fisher Scientific Investment FAQs
Manning & Napier Group first purchased Thermo Fisher Scientific Inc. (TMO) in Q3 2015, acquiring 504,380 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Thermo Fisher Scientific Inc. (TMO) for 41 quarters since Q3 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q3 2015, adding 504,380 shares worth $61.67 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 290,896 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $141.09 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 1.80% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's peak holding in Thermo Fisher Scientific Inc. (TMO) was 687,890 shares, as reported at the end of Q1 2016. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.